Amneal Pharmaceuticals Inc [AMRX] stock prices are up 0.45% to $8.88 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AMRX shares have lost -1.00% over the last week, with a monthly amount glided 11.70%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Amneal Pharmaceuticals Inc [NASDAQ: AMRX] stock has seen the most recent analyst activity on February 24, 2025, when JP Morgan upgraded its rating to a Overweight and also boosted its price target to $12 from $9. Previously, JP Morgan upgraded its rating to Neutral on September 06, 2024, and kept the price target unchanged to $9. Goldman upgraded its rating to a Buy and increased its price target to $6.50 on March 08, 2021. Guggenheim upgraded its rating to a Buy but $5.50 remained the price target by the analyst firm on December 14, 2020. Barclays upgraded its rating to Overweight for this stock on December 14, 2020, and upped its price target to $6. In a note dated July 27, 2020, Goldman initiated an Sell rating and provided a target price of $4 on this stock.
The stock price of Amneal Pharmaceuticals Inc [AMRX] has been fluctuating between $5.18 and $9.48 over the past year. Currently, Wall Street analysts expect the stock to reach $11.33 within the next 12 months. Amneal Pharmaceuticals Inc [NASDAQ: AMRX] shares were valued at $8.88 at the most recent close of the market. An investor can expect a potential return of 27.59% based on the average AMRX price forecast.
Analyzing the AMRX fundamentals
The Amneal Pharmaceuticals Inc [NASDAQ:AMRX] reported sales of 2.79B for trailing twelve months, representing a surge of 18.40%. Gross Profit Margin for this corporation currently stands at 0.37% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.04%. To continue investigating profitability, this company’s Return on Assets is posted at -0.03, Equity is 1.44 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-3.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.75 points at the first support level, and at 8.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.96, and for the 2nd resistance point, it is at 9.05.
Ratios To Look Out For
It’s worth pointing out that Amneal Pharmaceuticals Inc [NASDAQ:AMRX]’s Current Ratio is 1.41. Also, the Quick Ratio is 0.86, while the Cash Ratio stands at 0.1. Considering the valuation of this stock, the price to sales ratio is 0.99.
Transactions by insiders
Recent insider trading involved BOYER ANDREW S, Executive Vice President, that happened on Mar 05 ’25 when 0.12 million shares were sold. EVP, Chief Legal Officer, Daly Jason B. completed a deal on Mar 06 ’25 to sell 46936.0 shares. Meanwhile, EVP, Chief Legal Officer Daly Jason B. sold 43064.0 shares on Mar 05 ’25.
